Cargando…

Venous Thromboembolism and Thymic Hyperplasia in the Setting of Silent Graves' Disease

Venous thromboembolism is a common, yet serious life-threatening condition that has many well-recognized associations which include but are not limited to pregnancy, polycythemia, trauma, immobility, and malignancy. The pathophysiology behind the pro-coagulant effects of hyperthyroidism has been wel...

Descripción completa

Detalles Bibliográficos
Autores principales: Rayan, Melanie N, Jones, Tyler S, Ruiz de Villa, Ariel, Calestino, Matthew, Bazikian, Yvette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085705/
https://www.ncbi.nlm.nih.gov/pubmed/35547433
http://dx.doi.org/10.7759/cureus.23935
_version_ 1784703876852613120
author Rayan, Melanie N
Jones, Tyler S
Ruiz de Villa, Ariel
Calestino, Matthew
Bazikian, Yvette
author_facet Rayan, Melanie N
Jones, Tyler S
Ruiz de Villa, Ariel
Calestino, Matthew
Bazikian, Yvette
author_sort Rayan, Melanie N
collection PubMed
description Venous thromboembolism is a common, yet serious life-threatening condition that has many well-recognized associations which include but are not limited to pregnancy, polycythemia, trauma, immobility, and malignancy. The pathophysiology behind the pro-coagulant effects of hyperthyroidism has been well established; however, there are no current guidelines regarding deep venous thrombosis (DVT) surveillance in patients with hyperthyroidism. In this report, we discuss the case of a 36-year-old female with no significant past medical history (PMH) with the exception of a 15 pack-year smoking history, who presented to us with an extensive, rapidly-progressing lower extremity DVT. Despite aggressive treatment measures, she developed a pulmonary embolus in the hospital. During her stay, she was diagnosed with Graves’ disease by hormone profile and thyroid-stimulating hormone receptor (TSH-R) antibody positivity. Additionally, an incidental thymic mass, likely thymic hyperplasia, was found on imaging and presumed to be associated with Graves’ disease. This case study reports a difficult-to-treat venous thromboembolism in the setting of Graves’ disease along with a review of current literature and pathophysiology on the subject.
format Online
Article
Text
id pubmed-9085705
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-90857052022-05-10 Venous Thromboembolism and Thymic Hyperplasia in the Setting of Silent Graves' Disease Rayan, Melanie N Jones, Tyler S Ruiz de Villa, Ariel Calestino, Matthew Bazikian, Yvette Cureus Endocrinology/Diabetes/Metabolism Venous thromboembolism is a common, yet serious life-threatening condition that has many well-recognized associations which include but are not limited to pregnancy, polycythemia, trauma, immobility, and malignancy. The pathophysiology behind the pro-coagulant effects of hyperthyroidism has been well established; however, there are no current guidelines regarding deep venous thrombosis (DVT) surveillance in patients with hyperthyroidism. In this report, we discuss the case of a 36-year-old female with no significant past medical history (PMH) with the exception of a 15 pack-year smoking history, who presented to us with an extensive, rapidly-progressing lower extremity DVT. Despite aggressive treatment measures, she developed a pulmonary embolus in the hospital. During her stay, she was diagnosed with Graves’ disease by hormone profile and thyroid-stimulating hormone receptor (TSH-R) antibody positivity. Additionally, an incidental thymic mass, likely thymic hyperplasia, was found on imaging and presumed to be associated with Graves’ disease. This case study reports a difficult-to-treat venous thromboembolism in the setting of Graves’ disease along with a review of current literature and pathophysiology on the subject. Cureus 2022-04-07 /pmc/articles/PMC9085705/ /pubmed/35547433 http://dx.doi.org/10.7759/cureus.23935 Text en Copyright © 2022, Rayan et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Endocrinology/Diabetes/Metabolism
Rayan, Melanie N
Jones, Tyler S
Ruiz de Villa, Ariel
Calestino, Matthew
Bazikian, Yvette
Venous Thromboembolism and Thymic Hyperplasia in the Setting of Silent Graves' Disease
title Venous Thromboembolism and Thymic Hyperplasia in the Setting of Silent Graves' Disease
title_full Venous Thromboembolism and Thymic Hyperplasia in the Setting of Silent Graves' Disease
title_fullStr Venous Thromboembolism and Thymic Hyperplasia in the Setting of Silent Graves' Disease
title_full_unstemmed Venous Thromboembolism and Thymic Hyperplasia in the Setting of Silent Graves' Disease
title_short Venous Thromboembolism and Thymic Hyperplasia in the Setting of Silent Graves' Disease
title_sort venous thromboembolism and thymic hyperplasia in the setting of silent graves' disease
topic Endocrinology/Diabetes/Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085705/
https://www.ncbi.nlm.nih.gov/pubmed/35547433
http://dx.doi.org/10.7759/cureus.23935
work_keys_str_mv AT rayanmelanien venousthromboembolismandthymichyperplasiainthesettingofsilentgravesdisease
AT jonestylers venousthromboembolismandthymichyperplasiainthesettingofsilentgravesdisease
AT ruizdevillaariel venousthromboembolismandthymichyperplasiainthesettingofsilentgravesdisease
AT calestinomatthew venousthromboembolismandthymichyperplasiainthesettingofsilentgravesdisease
AT bazikianyvette venousthromboembolismandthymichyperplasiainthesettingofsilentgravesdisease